We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Baking Time Club sells baking supplies through a subscription service and direct to consumers by utilising their own website, Amazon and Etsy. Their aim is to provide customers with unusual and exiting items for the kitchen.
days to go: Expired investment: £64,940
An award-winning independent brewery that has been profitable every year since 2014 with worldwide distribution. Siren Craft Brew creates beers to ease those new to drinking, whilst producing adventurous flavours to continuously recapture and entice customers to return to their products. The business has won numerous awards for their beers. In their first year of launching, Ratebeer.com rated Siren Craft Brew as the 2nd Best New Brewery in the World and is repeatedly listed in their Top 100 Brewers every year. They have also been awarded the World Beer Cup medal and CAMRA’s Supreme Champion Beer of Britain for their flagship stout. Siren Craft Brew consists of a team of 28 people, whilst achieving £2.82m in annual turnover. In 2018 so far, their revenue has grown by 28% and their brewery has produced more than 2m pints this year. The company is now raising funds to package their products into cans, as they have already identified a canning manufacturer that will meet the business's needs to also create high-quality bottles for their beer. Any overfunding will result in the company being able to take their taproom experience to other areas, as well as increase beer production and produce drinks in a more efficient manner.
days to go: Expired investment: £1,215,170
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go: Expired investment: £192,280
A premium British handcrafted candy-maker seeking funds to expand and grow their business internationally. In addition to their own candy and confectionary, they also offer customers to create their own designs using natural colourings and the finest ingredients. Spun Candy have the rights to the Candy Crush app.

Pitch Rated

62%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £341,990
Run An Empire is a mobile app that is encouraging people to get outside and start jogging/ running more often using gamification. The idea behind the app is that users run around a particular area and then that area is claimed as their 'territory' until another user jogs that area and then claims it. 
days to go: Expired investment: £60,370
Positivitea is a range of teas based on the chakras. They are already stocked in over 80 locations throughout the UK and Europe including Urban Outfitters and Fenwick. The use of the proceeds raised will go towards expanding the team and getting Positivitea in more retail outlets and being used by more suppliers.
days to go: Expired investment: £103,640
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph